With one forecast predicting that cannabidiol sales in the U.S. will soar to $22 billion by 2022, it is no wonder that CBD is garnering enormous attention from Wall Street and investors. However, while many investors are seeking exposure to this growth via direct plays, there may be a sneakier, smarter and more stable play. CLICK HERE.
